Thomson Reuters exec joins Pfizer board

Pfizer Inc. has a new member of its board of directors: James C. Smith, president and chief executive of Thomson Reuters. The 54-year-old has been appointed to the Corporate Governance and Science and Technology committees of Pfizer's board.

Smith has held various leadership positions at Thomson Reuters, including CEO and chief operating officer of Thomson Reuters Professional Division. He also served as COO of Thomson and president and CEO of Thomson Learning's Academic and Reference Group.

Smith is a member of the International Business Council of the World Economic Forum and the Board of Directors of the Brazil-U.S. Business Council.


Loading comments...
Hide Comments